EUVIMEDEUVIMED entdecken
Kohortenstudie

Association of the modified Glasgow prognostic score and prognostic nutritional index with duration of oral anamorelin administration in patients with cancer cachexia: a retrospective cohort study

Kazuma Fujita iD, Yumiko Akamine, Haruka Igarashi, Yayoi Fukushi, Katsuya Sasaki, Koji Fukuda, Masafumi Kikuchi, Hiroyuki Shibata iD

Japanese Journal of Clinical Oncology · 2024

DOI: 10.1093/jjco/hyae086 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Japanese Journal of Clinical Oncology, 2024. Verfasst von Kazuma Fujita und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Akita University Hospital, Akita, Japan. Hauptthemen laut MEDLINE: Cachexia, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The modified Glasgow Prognostic Score (mGPS) and Prognostic Nutritional Index (PNI) are indicators of nutritional status in cancer patients; however, the effects of baseline mGPS and PNI on the duration of administration of the ghrelin receptor agonist anamorelin, which is used to treat cachexia in patients with cancer, are unclear. This study aimed to clarify the association of mGPS and PNI with the duration of oral anamorelin administration for patients who did not have beneficial effects from anamorelin.

Methods

The attending physician determined the duration of oral anamorelin administration based on discontinuation due to cancer progression, poor efficacy, adverse events, or death.

Results

The 12-week continuation rate of oral anamorelin was 30.4%. Univariate analysis revealed that an Eastern Cooperative Oncology Group performance status (ECOG-PS) of ≥2 (P < .001), concurrent chemotherapy (P = .002), albumin level (P = .005), C-reactive protein level (P = .013), and a mGPS of 2 (P = .014) were statistically significant predictors of the 12-week continuation rate of oral anamorelin. In the multivariate analysis, a mGPS of 2 remained a significant risk factor, and the ECOG-PS and concurrent chemotherapy had no effect on the association between the mGPS and 12-week continuation rate of oral anamorelin.

Conclusion

Patients with a mGPS of 2, compared with mGPS of 0 or 1, are less likely to maintain oral anamorelin therapy, regardless of the ECOG-PS or concurrent chemotherapy. Therefore, it is necessary to consider initiating anamorelin administration at mGPS 0 or 1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CachexiaNeoplasmsHumansMaleFemaleRetrospective StudiesAgedMiddle AgedPrognosisAdministration, OralOligopeptidesNutrition AssessmentAged, 80 and overNutritional StatusAzetidinesAdultHydrazines

Stichwörter der Autor:innen

C-reactive proteinalbuminanamorelincancer cachexiamodified Glasgow prognostic score

Substanzen

anamorelinOligopeptidesAzetidinesHydrazines

Autor:innen und Institutionen

  • Department of Pharmacy, Akita University Hospital, Akita, Japan.
  • Department of Clinical Oncology, Akita University, Akita, Japan.

ORCID-Profile: Kazuma Fujita, Hiroyuki Shibata

Zitieren

APA

Fujita, K., Akamine, Y., Igarashi, H., Fukushi, Y., Sasaki, K., Fukuda, K., Kikuchi, M., & Shibata, H. (2024). Association of the modified Glasgow prognostic score and prognostic nutritional index with duration of oral anamorelin administration in patients with cancer cachexia: a retrospective cohort study. Japanese Journal of Clinical Oncology. https://doi.org/10.1093/jjco/hyae086

Vancouver

Fujita K, Akamine Y, Igarashi H, Fukushi Y, Sasaki K, Fukuda K, et al. Association of the modified Glasgow prognostic score and prognostic nutritional index with duration of oral anamorelin administration in patients with cancer cachexia: a retrospective cohort study. Japanese Journal of Clinical Oncology. 2024. doi:10.1093/jjco/hyae086

BibTeX
@article{Fujita2024,
  author = {Fujita, Kazuma and Akamine, Yumiko and Igarashi, Haruka and Fukushi, Yayoi and Sasaki, Katsuya and Fukuda, Koji and Kikuchi, Masafumi and Shibata, Hiroyuki},
  title = {Association of the modified Glasgow prognostic score and prognostic nutritional index with duration of oral anamorelin administration in patients with cancer cachexia: a retrospective cohort study},
  journal = {Japanese Journal of Clinical Oncology},
  year = {2024},
  doi = {10.1093/jjco/hyae086}
}
Kostenlos starten →